Sep 28, 2022 by The Beat Maker - 0 Comments
- Equillium (NASDAQ: EQ) Soars After Positive Results From Clinical Study TipRanks
- Why Is Equillium (EQ) Stock Soaring 20% Today? InvestorPlace
- Equillium (EQ) Announces Positive Interim Results from the EQUALISE Study in Subjects with Lupus Nephritis StreetInsider.com
- Here’s Why Equillium Stock Is Skyrocketing – Equillium (NASDAQ:EQ) Benzinga
- View Full Coverage on Google News